Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pico-Salax Colonic Preparation Study
NCT00885430Phase 4Completed
- Sponsor
- Queen's University
- Start
- Jul 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium picosulfate + magnesium oxide + citric acid, sponsored by Queen's University. Primary endpoints: Serum electrolytes at 48 hours and Patient hemodynamics at 48 hours. Started Jul 2008; status: completed.
02
Drugs
sodium picosulfate + magnesium oxide + citric acid
Beyond the preview
Go deeper on NCT00885430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885430.